Fareed Khawaja, MBBS
Department of Infectious Diseases, Infection Control, and Employee Health, Division of Internal Medicine
Present Title & Affiliation
Primary Appointment
Assistant Professor, Department of Infectious Diseases, Infection Control and Employee Health, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 2013 | Aga Khan University Medical College, Karachi, PAK, MBBS, Medicine and Surgery |
Postgraduate Training
| 2017-2019 | Clinical Fellowship, The University of Texas Health Science Center at Houston/MD Anderson, Houston, TX |
| 2014-2017 | Clinical Residency, The University of Texas Health Science Center at Houston, Houston, TX |
Board Certifications
| 2019 | American Board of Internal Medicine Specialty-Infectious Diseases |
| 2017 | American Board of Internal Medicine |
Experience & Service
Other Appointments/Responsibilities
Research Trainee, The Mayo Clinic, Rochester, MN, 2013 - 2014
Honors & Awards
| 2008 | Pre-Med Honor for all A's |
| 2007 | Principal's List |
| 2006 | Pre-Med Honor for all A's |
Professional Memberships
Selected Publications
Peer-Reviewed Articles
- Angelidakis G, Khawaja F, Mulanovich VE, Dailey-Garnes N, Ariza-Heredia E, Chemaly RF. Combination of Baloxavir and Oseltamivir for Treatment of Severe Influenza Infection in Hematopoietic Cell Transplant Recipients: A Novel Treatment Strategy for a High-risk Population. Microbes Infect 24(3):104895, 2022. e-Pub 2021. PMID: 34756990.
- Handley G, Khawaja F, Kondapi DS, Lee HJ, Kaufman GP, Neelapu SS, Fayad LE, Tummala S, Chi L, Strati P, Mulanovich VE. Human herpesvirus 6 myelitis after chimeric antigen receptor T-cell therapy. Int J Infect Dis 112:327-329, 2021. e-Pub 2021. PMID: 34600133.
- Sassine J, Khawaja F, Shigle TL, Handy V, Foolad F, Aitken SL, Jiang Y, Champlin R, Shpall E, Rezvani K, Ariza-Heredia EJ, Chemaly RF. Refractory and Resistant Cytomegalovirus After Hematopoietic Cell Transplant in the Letermovir Primary Prophylaxis Era. Clin Infect Dis 73(8):1346-1354, 2021. PMID: 33830182.
- Malek AE, Adachi JA, Mulanovich VE, Sassine J, Raad II, McConn K, Seiler GT, Dhal U, Khawaja F, Chemaly RF. Immune reconstitution and severity of COVID-19 among hematopoietic cell transplant recipients. Transpl Infect Dis 23(4):e13606, 2021. e-Pub 2021. PMID: 33755273.
- Ariza-Heredia EJ, Frenzel E, Cantu S, Carlson M, Thomas G, Khawaja F, Raad II, Chemaly RF. Surveillance and identification of clusters of healthcare workers with coronavirus disease 2019 (COVID-19): Multidimensional interventions at a comprehensive cancer center. Infect Control Hosp Epidemiol 42(7):797-802, 2021. e-Pub 2020. PMID: 33183368.
- Karri PV, Torres CA, Dailey Garnes NJ, Ronen S, Khawaja F, Bhatti MM, Hosing C, Patel AB. Disseminated atypical mycobacterial infection in an allogeneic stem cell transplant recipient. Dermatol Online J 27(6), 2021. e-Pub 2021. PMID: 34387060.
- Simmons SE, Carrion R, Alfson KJ, Staples HM, Jinadatha C, Jarvis WR, Sampathkumar P, Chemaly RF, Khawaja F, Povroznik M, Jackson S, Kaye KS, Rodriguez RM, Stibich MA. Deactivation of SARS-CoV-2 with pulsed-xenon ultraviolet light: Implications for environmental COVID-19 control. Infect Control Hosp Epidemiol 42(2):127-130, 2021. e-Pub 2020. PMID: 32741425.
- Khawaja F, Batista MV, El Haddad L, Chemaly RF. Resistant or refractory cytomegalovirus infections after hematopoietic cell transplantation: diagnosis and management. Curr Opin Infect Dis 32(6):565-574, 2019. e-Pub 2019. PMID: 31567572.